Sam Chun Dang Pharm. Statistics

Total Valuation

Sam Chun Dang Pharm. has a market cap or net worth of KRW 3.61 trillion. The enterprise value is 3.59 trillion.

Market Cap	3.61T
Enterprise Value	3.59T

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Sam Chun Dang Pharm. has 23.26 million shares outstanding. The number of shares has increased by 4.56% in one year.

Current Share Class	n/a
Shares Outstanding	23.26M
Shares Change (YoY)	+4.56%
Shares Change (QoQ)	+2.06%
Owned by Insiders (%)	6.98%
Owned by Institutions (%)	9.52%
Float	14.44M

Valuation Ratios

The trailing PE ratio is 707.26.

PE Ratio	707.26
Forward PE	n/a
PS Ratio	17.22
PB Ratio	13.12
P/TBV Ratio	14.26
P/FCF Ratio	167.97
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 257.59, with an EV/FCF ratio of 167.06.

EV / Earnings	703.43
EV / Sales	17.26
EV / EBITDA	257.59
EV / EBIT	n/a
EV / FCF	167.06

Financial Position

The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.17.

Current Ratio	4.10
Quick Ratio	3.39
Debt / Equity	0.17
Debt / EBITDA	4.34
Debt / FCF	2.81
Interest Coverage	4.71

Financial Efficiency

Return on equity (ROE) is 3.35% and return on invested capital (ROIC) is 0.84%.

Return on Equity (ROE)	3.35%
Return on Assets (ROA)	0.72%
Return on Capital (ROIC)	0.84%
Revenue Per Employee	509.10M
Profits Per Employee	12.49M
Employee Count	409
Asset Turnover	0.46
Inventory Turnover	2.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +89.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+89.24%
50-Day Moving Average	120,824.00
200-Day Moving Average	132,676.50
Relative Strength Index (RSI)	67.55
Average Volume (20 Days)	578,389

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sam Chun Dang Pharm. had revenue of KRW 208.22 billion and earned 5.11 billion in profits. Earnings per share was 221.48.

Revenue	208.22B
Gross Profit	98.29B
Operating Income	5.19B
Pretax Income	11.89B
Net Income	5.11B
EBITDA	13.96B
EBIT	5.19B
Earnings Per Share (EPS)	221.48

Full Income Statement

Balance Sheet

The company has 161.03 billion in cash and 60.56 billion in debt, giving a net cash position of 100.47 billion or 4,320.05 per share.

Cash & Cash Equivalents	161.03B
Total Debt	60.56B
Net Cash	100.47B
Net Cash Per Share	4,320.05
Equity (Book Value)	356.38B
Book Value Per Share	11,844.38
Working Capital	180.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 38.38 billion and capital expenditures -16.87 billion, giving a free cash flow of 21.52 billion.

Operating Cash Flow	38.38B
Capital Expenditures	-16.87B
Free Cash Flow	21.52B
FCF Per Share	925.14

Full Cash Flow Statement

Margins

Gross margin is 47.20%, with operating and profit margins of 2.49% and 2.45%.

Gross Margin	47.20%
Operating Margin	2.49%
Pretax Margin	5.71%
Profit Margin	2.45%
EBITDA Margin	6.70%
EBIT Margin	2.49%
FCF Margin	10.33%

Dividends & Yields

Sam Chun Dang Pharm. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	17.42%
Buyback Yield	-4.56%
Shareholder Yield	-4.56%
Earnings Yield	0.14%
FCF Yield	0.60%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sam Chun Dang Pharm. has an Altman Z-Score of 11.97.

Altman Z-Score	11.97
Piotroski F-Score	n/a